ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Candesartan and Hydrochlorothiazide Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-9W7144
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Candesartan and Hydrochlorothiazide Market Insights Forecast to 2028
BUY CHAPTERS

Global Candesartan and Hydrochlorothiazide Market Research Report 2025

Code: QYRE-Auto-9W7144
Report
August 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
ANI Pharmaceuticals
TEVA
Mylan NV
Dr. Reddy’s Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
Macleods

Candesartan and Hydrochlorothiazide Market Size

The global market for Candesartan and Hydrochlorothiazide was valued at US$ 343 million in the year 2024 and is projected to reach a revised size of US$ 526 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Candesartan and Hydrochlorothiazide Market

Candesartan and Hydrochlorothiazide Market

Candesartan and Hydrochlorothiazide contains 2 medications: candesartan and hydrochlorothiazide. Candesartan belongs to a family of medications known as angiotensin II receptor blockers. Hydrochlorothiazide belongs to a family of medications known as diuretics (or "water pills"). This combination medication is used to lower high blood pressure.
North American market for Candesartan and Hydrochlorothiazide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Candesartan and Hydrochlorothiazide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Candesartan and Hydrochlorothiazide include AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical, MACLEODS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Candesartan and Hydrochlorothiazide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Candesartan and Hydrochlorothiazide.
The Candesartan and Hydrochlorothiazide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Candesartan and Hydrochlorothiazide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Candesartan and Hydrochlorothiazide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Candesartan and Hydrochlorothiazide Market Report

Report Metric Details
Report Name Candesartan and Hydrochlorothiazide Market
Accounted market size in year US$ 343 million
Forecasted market size in 2031 US$ 526 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 16/12.5
  • 32/12.5
  • 32/25
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical, MACLEODS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Candesartan and Hydrochlorothiazide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Candesartan and Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Candesartan and Hydrochlorothiazide Market growing?

Ans: The Candesartan and Hydrochlorothiazide Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Candesartan and Hydrochlorothiazide Market size in 2031?

Ans: The Candesartan and Hydrochlorothiazide Market size in 2031 will be US$ 526 million.

Who are the main players in the Candesartan and Hydrochlorothiazide Market report?

Ans: The main players in the Candesartan and Hydrochlorothiazide Market are AstraZeneca, ANI Pharmaceuticals, TEVA, Mylan, Dr. Reddy's Laboratories, Zydus Pharmaceuticals, Prinston Pharmaceutical, MACLEODS

What are the Application segmentation covered in the Candesartan and Hydrochlorothiazide Market report?

Ans: The Applications covered in the Candesartan and Hydrochlorothiazide Market report are Adults, Geriatric

What are the Type segmentation covered in the Candesartan and Hydrochlorothiazide Market report?

Ans: The Types covered in the Candesartan and Hydrochlorothiazide Market report are 16/12.5, 32/12.5, 32/25

Recommended Reports

Hypertension Drugs

Diuretics Market

Sartans Drugs

1 Candesartan and Hydrochlorothiazide Market Overview
1.1 Product Definition
1.2 Candesartan and Hydrochlorothiazide by Type
1.2.1 Global Candesartan and Hydrochlorothiazide Market Value Comparison by Type (2024 VS 2031)
1.2.2 16/12.5
1.2.3 32/12.5
1.2.4 32/25
1.3 Candesartan and Hydrochlorothiazide by Application
1.3.1 Global Candesartan and Hydrochlorothiazide Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Geriatric
1.4 Global Candesartan and Hydrochlorothiazide Market Size Estimates and Forecasts
1.4.1 Global Candesartan and Hydrochlorothiazide Revenue 2020-2031
1.4.2 Global Candesartan and Hydrochlorothiazide Sales 2020-2031
1.4.3 Global Candesartan and Hydrochlorothiazide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Candesartan and Hydrochlorothiazide Market Competition by Manufacturers
2.1 Global Candesartan and Hydrochlorothiazide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Candesartan and Hydrochlorothiazide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Candesartan and Hydrochlorothiazide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Product Type & Application
2.7 Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Date of Enter into This Industry
2.8 Global Candesartan and Hydrochlorothiazide Market Competitive Situation and Trends
2.8.1 Global Candesartan and Hydrochlorothiazide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Candesartan and Hydrochlorothiazide Players Market Share by Revenue
2.8.3 Global Candesartan and Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Candesartan and Hydrochlorothiazide Market Scenario by Region
3.1 Global Candesartan and Hydrochlorothiazide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Candesartan and Hydrochlorothiazide Sales by Region: 2020-2031
3.2.1 Global Candesartan and Hydrochlorothiazide Sales by Region: 2020-2025
3.2.2 Global Candesartan and Hydrochlorothiazide Sales by Region: 2026-2031
3.3 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2020-2031
3.3.1 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2020-2025
3.3.2 Global Candesartan and Hydrochlorothiazide Revenue by Region: 2026-2031
3.4 North America Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.4.1 North America Candesartan and Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Candesartan and Hydrochlorothiazide Sales by Country (2020-2031)
3.4.3 North America Candesartan and Hydrochlorothiazide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.5.1 Europe Candesartan and Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Candesartan and Hydrochlorothiazide Sales by Country (2020-2031)
3.5.3 Europe Candesartan and Hydrochlorothiazide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Candesartan and Hydrochlorothiazide Market Facts & Figures by Region
3.6.1 Asia Pacific Candesartan and Hydrochlorothiazide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Candesartan and Hydrochlorothiazide Sales by Region (2020-2031)
3.6.3 Asia Pacific Candesartan and Hydrochlorothiazide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.7.1 Latin America Candesartan and Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Candesartan and Hydrochlorothiazide Sales by Country (2020-2031)
3.7.3 Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Candesartan and Hydrochlorothiazide Market Facts & Figures by Country
3.8.1 Middle East and Africa Candesartan and Hydrochlorothiazide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Candesartan and Hydrochlorothiazide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2020-2031)
4.1.1 Global Candesartan and Hydrochlorothiazide Sales by Type (2020-2025)
4.1.2 Global Candesartan and Hydrochlorothiazide Sales by Type (2026-2031)
4.1.3 Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2020-2031)
4.2 Global Candesartan and Hydrochlorothiazide Revenue by Type (2020-2031)
4.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Type (2020-2025)
4.2.2 Global Candesartan and Hydrochlorothiazide Revenue by Type (2026-2031)
4.2.3 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2020-2031)
4.3 Global Candesartan and Hydrochlorothiazide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2020-2031)
5.1.1 Global Candesartan and Hydrochlorothiazide Sales by Application (2020-2025)
5.1.2 Global Candesartan and Hydrochlorothiazide Sales by Application (2026-2031)
5.1.3 Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2020-2031)
5.2 Global Candesartan and Hydrochlorothiazide Revenue by Application (2020-2031)
5.2.1 Global Candesartan and Hydrochlorothiazide Revenue by Application (2020-2025)
5.2.2 Global Candesartan and Hydrochlorothiazide Revenue by Application (2026-2031)
5.2.3 Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2020-2031)
5.3 Global Candesartan and Hydrochlorothiazide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Candesartan and Hydrochlorothiazide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 ANI Pharmaceuticals
6.2.1 ANI Pharmaceuticals Company Information
6.2.2 ANI Pharmaceuticals Description and Business Overview
6.2.3 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
6.2.5 ANI Pharmaceuticals Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Company Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 TEVA Candesartan and Hydrochlorothiazide Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Candesartan and Hydrochlorothiazide Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Dr. Reddy's Laboratories
6.5.1 Dr. Reddy's Laboratories Company Information
6.5.2 Dr. Reddy's Laboratories Description and Business Overview
6.5.3 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product Portfolio
6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.6 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Company Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product Portfolio
6.6.5 Zydus Pharmaceuticals Recent Developments/Updates
6.7 Prinston Pharmaceutical
6.7.1 Prinston Pharmaceutical Company Information
6.7.2 Prinston Pharmaceutical Description and Business Overview
6.7.3 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product Portfolio
6.7.5 Prinston Pharmaceutical Recent Developments/Updates
6.8 MACLEODS
6.8.1 MACLEODS Company Information
6.8.2 MACLEODS Description and Business Overview
6.8.3 MACLEODS Candesartan and Hydrochlorothiazide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 MACLEODS Candesartan and Hydrochlorothiazide Product Portfolio
6.8.5 MACLEODS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Candesartan and Hydrochlorothiazide Industry Chain Analysis
7.2 Candesartan and Hydrochlorothiazide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Candesartan and Hydrochlorothiazide Production Mode & Process Analysis
7.4 Candesartan and Hydrochlorothiazide Sales and Marketing
7.4.1 Candesartan and Hydrochlorothiazide Sales Channels
7.4.2 Candesartan and Hydrochlorothiazide Distributors
7.5 Candesartan and Hydrochlorothiazide Customer Analysis
8 Candesartan and Hydrochlorothiazide Market Dynamics
8.1 Candesartan and Hydrochlorothiazide Industry Trends
8.2 Candesartan and Hydrochlorothiazide Market Drivers
8.3 Candesartan and Hydrochlorothiazide Market Challenges
8.4 Candesartan and Hydrochlorothiazide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
ANI Pharmaceuticals
TEVA
Mylan NV
Dr. Reddy’s Laboratories
Zydus Pharmaceuticals
Prinston Pharmaceutical
Macleods
List of Tables
 Table 1. Global Candesartan and Hydrochlorothiazide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Candesartan and Hydrochlorothiazide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Candesartan and Hydrochlorothiazide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Candesartan and Hydrochlorothiazide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Candesartan and Hydrochlorothiazide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Candesartan and Hydrochlorothiazide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Candesartan and Hydrochlorothiazide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Candesartan and Hydrochlorothiazide Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Candesartan and Hydrochlorothiazide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Product Type & Application
 Table 12. Global Key Manufacturers of Candesartan and Hydrochlorothiazide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Candesartan and Hydrochlorothiazide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Candesartan and Hydrochlorothiazide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Candesartan and Hydrochlorothiazide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Candesartan and Hydrochlorothiazide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Candesartan and Hydrochlorothiazide Sales Market Share by Region (2020-2025)
 Table 19. Global Candesartan and Hydrochlorothiazide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Candesartan and Hydrochlorothiazide Sales Market Share by Region (2026-2031)
 Table 21. Global Candesartan and Hydrochlorothiazide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2020-2025)
 Table 23. Global Candesartan and Hydrochlorothiazide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2026-2031)
 Table 25. North America Candesartan and Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Candesartan and Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Candesartan and Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Candesartan and Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Candesartan and Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Candesartan and Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Candesartan and Hydrochlorothiazide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Candesartan and Hydrochlorothiazide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Candesartan and Hydrochlorothiazide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Candesartan and Hydrochlorothiazide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Candesartan and Hydrochlorothiazide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Candesartan and Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Candesartan and Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Candesartan and Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Candesartan and Hydrochlorothiazide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Candesartan and Hydrochlorothiazide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Candesartan and Hydrochlorothiazide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Candesartan and Hydrochlorothiazide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Candesartan and Hydrochlorothiazide Sales (K Units) by Type (2020-2025)
 Table 51. Global Candesartan and Hydrochlorothiazide Sales (K Units) by Type (2026-2031)
 Table 52. Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2020-2025)
 Table 53. Global Candesartan and Hydrochlorothiazide Sales Market Share by Type (2026-2031)
 Table 54. Global Candesartan and Hydrochlorothiazide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Candesartan and Hydrochlorothiazide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2020-2025)
 Table 57. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Type (2026-2031)
 Table 58. Global Candesartan and Hydrochlorothiazide Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Candesartan and Hydrochlorothiazide Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Candesartan and Hydrochlorothiazide Sales (K Units) by Application (2020-2025)
 Table 61. Global Candesartan and Hydrochlorothiazide Sales (K Units) by Application (2026-2031)
 Table 62. Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2020-2025)
 Table 63. Global Candesartan and Hydrochlorothiazide Sales Market Share by Application (2026-2031)
 Table 64. Global Candesartan and Hydrochlorothiazide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Candesartan and Hydrochlorothiazide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2020-2025)
 Table 67. Global Candesartan and Hydrochlorothiazide Revenue Market Share by Application (2026-2031)
 Table 68. Global Candesartan and Hydrochlorothiazide Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Candesartan and Hydrochlorothiazide Price (USD/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Candesartan and Hydrochlorothiazide Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. ANI Pharmaceuticals Company Information
 Table 76. ANI Pharmaceuticals Description and Business Overview
 Table 77. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. ANI Pharmaceuticals Candesartan and Hydrochlorothiazide Product
 Table 79. ANI Pharmaceuticals Recent Developments/Updates
 Table 80. TEVA Company Information
 Table 81. TEVA Description and Business Overview
 Table 82. TEVA Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. TEVA Candesartan and Hydrochlorothiazide Product
 Table 84. TEVA Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan Candesartan and Hydrochlorothiazide Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Dr. Reddy's Laboratories Company Information
 Table 91. Dr. Reddy's Laboratories Description and Business Overview
 Table 92. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Dr. Reddy's Laboratories Candesartan and Hydrochlorothiazide Product
 Table 94. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 95. Zydus Pharmaceuticals Company Information
 Table 96. Zydus Pharmaceuticals Description and Business Overview
 Table 97. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Zydus Pharmaceuticals Candesartan and Hydrochlorothiazide Product
 Table 99. Zydus Pharmaceuticals Recent Developments/Updates
 Table 100. Prinston Pharmaceutical Company Information
 Table 101. Prinston Pharmaceutical Description and Business Overview
 Table 102. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Prinston Pharmaceutical Candesartan and Hydrochlorothiazide Product
 Table 104. Prinston Pharmaceutical Recent Developments/Updates
 Table 105. MACLEODS Company Information
 Table 106. MACLEODS Description and Business Overview
 Table 107. MACLEODS Candesartan and Hydrochlorothiazide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. MACLEODS Candesartan and Hydrochlorothiazide Product
 Table 109. MACLEODS Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Candesartan and Hydrochlorothiazide Distributors List
 Table 113. Candesartan and Hydrochlorothiazide Customers List
 Table 114. Candesartan and Hydrochlorothiazide Market Trends
 Table 115. Candesartan and Hydrochlorothiazide Market Drivers
 Table 116. Candesartan and Hydrochlorothiazide Market Challenges
 Table 117. Candesartan and Hydrochlorothiazide Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Candesartan and Hydrochlorothiazide
 Figure 2. Global Candesartan and Hydrochlorothiazide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Candesartan and Hydrochlorothiazide Market Share by Type: 2024 & 2031
 Figure 4. 16/12.5 Product Picture
 Figure 5. 32/12.5 Product Picture
 Figure 6. 32/25 Product Picture
 Figure 7. Global Candesartan and Hydrochlorothiazide Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Candesartan and Hydrochlorothiazide Market Share by Application: 2024 & 2031
 Figure 9. Adults
 Figure 10. Geriatric
 Figure 11. Global Candesartan and Hydrochlorothiazide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Candesartan and Hydrochlorothiazide Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Candesartan and Hydrochlorothiazide Sales (2020-2031) & (K Units)
 Figure 14. Global Candesartan and Hydrochlorothiazide Average Price (USD/Unit) & (2020-2031)
 Figure 15. Candesartan and Hydrochlorothiazide Report Years Considered
 Figure 16. Candesartan and Hydrochlorothiazide Sales Share by Manufacturers in 2024
 Figure 17. Global Candesartan and Hydrochlorothiazide Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Candesartan and Hydrochlorothiazide Players: Market Share by Revenue in Candesartan and Hydrochlorothiazide in 2024
 Figure 19. Candesartan and Hydrochlorothiazide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Candesartan and Hydrochlorothiazide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Candesartan and Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 22. North America Candesartan and Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Candesartan and Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 26. Europe Candesartan and Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Candesartan and Hydrochlorothiazide Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Candesartan and Hydrochlorothiazide Revenue Market Share by Region (2020-2031)
 Figure 34. China Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Candesartan and Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Candesartan and Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Candesartan and Hydrochlorothiazide Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Candesartan and Hydrochlorothiazide Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Candesartan and Hydrochlorothiazide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Candesartan and Hydrochlorothiazide by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Candesartan and Hydrochlorothiazide by Type (2020-2031)
 Figure 56. Global Candesartan and Hydrochlorothiazide Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Candesartan and Hydrochlorothiazide by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Candesartan and Hydrochlorothiazide by Application (2020-2031)
 Figure 59. Global Candesartan and Hydrochlorothiazide Price (USD/Unit) by Application (2020-2031)
 Figure 60. Candesartan and Hydrochlorothiazide Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Telmisartan and Hydrochlorothiazide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Losartan and Hydrochlorothiazide Tablets Market Research Report 2024
Global Irbesartan Market Research Report 2024
Global Irbesartan Amlodipine Tablets Market Research Report 2024
Global Sartan series Drugs Market Research Report 2024
Candesartan Cilexetil Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irbesartan Tablets Market Insights Forecast to 2030
Global Hypertension and Heart Failure Drugs Market Insights Forecast to 2030
Global Amlodipine Atorvastatin Market Insights Forecast to 2030
lrbesartan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chlorothiazide Sodium Injection Market Research Report 2024
Treatment Resistant Hypertension Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irbesartan API Market Research Report 2024
Global Amlodipine and Olmesartan Market Insights Forecast to 2030
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Losartan Potassium Hydrochlorothiazide Tablet Market Research Report 2024
Global Telmisartan Tablet Market Research Report 2024
Global Valsartan Capsules Market Research Report 2024
Global Coronary Heart Disease Medication Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions